These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20385837)

  • 1. Evolution-guided discovery and recoding of allosteric pathway specificity determinants in psychoactive bioamine receptors.
    Rodriguez GJ; Yao R; Lichtarge O; Wensel TG
    Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7787-92. PubMed ID: 20385837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric coupling and biased agonism in G protein-coupled receptors.
    Bock A; Bermudez M
    FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common activation mechanism of class A GPCRs.
    Zhou Q; Yang D; Wu M; Guo Y; Guo W; Zhong L; Cai X; Dai A; Jang W; Shakhnovich EI; Liu ZJ; Stevens RC; Lambert NA; Babu MM; Wang MW; Zhao S
    Elife; 2019 Dec; 8():. PubMed ID: 31855179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramolecular allosteric communication in dopamine D2 receptor revealed by evolutionary amino acid covariation.
    Sung YM; Wilkins AD; Rodriguez GJ; Wensel TG; Lichtarge O
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3539-44. PubMed ID: 26979958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved Residues Control the T1R3-Specific Allosteric Signaling Pathway of the Mammalian Sweet-Taste Receptor.
    Chéron JB; Soohoo A; Wang Y; Golebiowski J; Antonczak S; Jiang P; Fiorucci S
    Chem Senses; 2019 May; 44(5):303-310. PubMed ID: 30893427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residues and residue pairs of evolutionary importance differentially direct signaling bias of D2 dopamine receptors.
    Terrón-Díaz ME; Wright SJ; Agosto MA; Lichtarge O; Wensel TG
    J Biol Chem; 2019 Dec; 294(50):19279-19291. PubMed ID: 31676688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary trace of G protein-coupled receptors reveals clusters of residues that determine global and class-specific functions.
    Madabushi S; Gross AK; Philippi A; Meng EC; Wensel TG; Lichtarge O
    J Biol Chem; 2004 Feb; 279(9):8126-32. PubMed ID: 14660595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Molecular Basis of G Protein-Coupled Receptor Activation.
    Weis WI; Kobilka BK
    Annu Rev Biochem; 2018 Jun; 87():897-919. PubMed ID: 29925258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for a broad but selective ligand spectrum of a mouse olfactory receptor: mapping the odorant-binding site.
    Katada S; Hirokawa T; Oka Y; Suwa M; Touhara K
    J Neurosci; 2005 Feb; 25(7):1806-15. PubMed ID: 15716417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
    Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
    Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased Ligands Differentially Shape the Conformation of the Extracellular Loop Region in 5-HT
    Denzinger K; Nguyen TN; Noonan T; Wolber G; Bermudez M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
    Fronik P; Gaiser BI; Sejer Pedersen D
    J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation.
    Han Y; Moreira IS; Urizar E; Weinstein H; Javitch JA
    Nat Chem Biol; 2009 Sep; 5(9):688-95. PubMed ID: 19648932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mechanism of allostery in a G protein-coupled receptor dimer.
    Lane JR; Donthamsetti P; Shonberg J; Draper-Joyce CJ; Dentry S; Michino M; Shi L; López L; Scammells PJ; Capuano B; Sexton PM; Javitch JA; Christopoulos A
    Nat Chem Biol; 2014 Sep; 10(9):745-52. PubMed ID: 25108820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
    Keov P; Sexton PM; Christopoulos A
    Neuropharmacology; 2011 Jan; 60(1):24-35. PubMed ID: 20637785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating structural and mutagenesis data to elucidate GPCR ligand binding.
    Munk C; Harpsøe K; Hauser AS; Isberg V; Gloriam DE
    Curr Opin Pharmacol; 2016 Oct; 30():51-58. PubMed ID: 27475047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric drugs and seven transmembrane receptors.
    Kenakin T
    Curr Top Med Chem; 2013; 13(1):5-13. PubMed ID: 23409762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.